A Day Up For Arcturus Therapeutics Holdings Inc.
Fri, Nov 27, 2020 at 05:30 PM
Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) rocketted at $76, representing a gain of 25.4%. On Thu 26 Nov 20, ARCT:NASDAQ hit a New 2-Week Intraday High of $63.68. The stock got featured on our News Catalysts scanner on Tue 17 Nov 20 at 08:52 AM in the 'BIOTECH' category. From Wed 11 Nov 20, the stock recorded 70.00% Up Days and 72.73% Green Days
The stock spiked on Fri 21 Aug 20 at $66.24 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ)
Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
Top 10 Gainers:
- SCWorx Corp. (WORX:NASDAQ), 77.6%
- Oramed Pharmaceuticals Inc. (ORMP:NASDAQ), 37.77%
- FreightCar America, Inc. (RAIL:NASDAQ), 37.31%
- ReneSola Ltd (SOL:NYSE), 33.1%
- Sundial Growers Inc. (SNDL:NASDAQ), 32.86%
- India Globalization Capital, Inc. (IGC:NYSEMKT), 30.14%
- Apex Technology Acquisition Corporation (APXT:NASDAQ), 29.21%
- NantKwest, Inc. (NK:NASDAQ), 28.25%
- FSTX (FSTX:NASDAQ), 27.78%
- Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ), 25.35%